| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9940658 | American Journal of Hypertension | 2005 | 5 Pages | 
Abstract
												Based on the study results, ARR and low renin activity may predict the response to spironolactone in never-treated hypertensive patients but not in patients taking antihypertensive drugs, possibly because of the effect of these agents on ARR. In such patients a trial of spironolactone is required to assess the BP response.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Azra Mahmud, Mohammed Mahgoub, Mary Hall, John Feely, 
											